Reza Taheri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reza Taheri has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Nafiseh Jirofti
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
5 shared publications - Davod Mohebbi-Kalhori
Chemical Engineering Department, University of Sistan and Baluchestan, Zahedan, Iran
4 shared publications - Gholam Hosein Kazemzadeh
Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4 shared publications - Afsaneh Jahani
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Ali Moradi
Orthopedic Research Center, Department of Orthopedic Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications Davod Mohebbi-Kalhori
2 shared publications
Latest Publications
- Open Access
- 4 November 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-15
Development of a novel small diameter vascular graft based on an electrospun blend PET/PU scaffold: from fabrication to structural, mechanical, and in vitro evaluation
The development of small-diameter vascular grafts (SDVGs) remains a significant challenge and unsolved problem due to issues with compliance mismatch, thrombosis, and graft failure. This study explores electrospun blended scaffolds made from polyethylene terephthalate (PET) and polyurethane (PU), both Food and Drug Administration (FDA)-approved polymers, as potential candidates for small-diameter vascular applications. Nanofibrous scaffolds composed of blended PET and PU were fabricated using the electrospinning method. The morphological and chemical properties of the scaffolds were characterized by FE-SEM, porosity measurement, FTIR, and DSC. Comprehensive mechanical evaluations, including tensile strength, burst pressure, and compliance, were performed. Biocompatibility was assessed by examining cellular adhesion, proliferation, and viability on the scaffolds. For in vivo evaluation, the electrospun scaffolds were subcutaneously implanted in rats. The PET/PU blended scaffolds exhibited excellent physicochemical compatibility, with mechanical properties within the range of native small-diameter blood vessels (SDBVs). Burst pressure and compliance evaluations demonstrated the ability of the PET/PU blend to mitigate the compliance mismatch commonly observed in synthetic grafts. Additionally, the scaffolds supported strong human cell adhesion, proliferation, and high cell viability, indicating good biocompatibility. No signs of necrosis, calcification, severe fibrosis, inflammation, or foreign body granulomatous reaction were observed following subcutaneous implantation of the scaffolds. Electrospun PET/PU scaffolds offer promising mechanical and biocompatible properties for SDVGs applications. The ability to address compliance mismatch, combined with excellent cellular support, positions these scaffolds as a strong candidate for clinical use. However, further preclinical and clinical studies are necessary to validate their long-term safety, performance, and commercial viability.
- 4 November 2025
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 36 (1) , 1-15
Open AccessDevelopment of a novel small diameter vascular graft based on an electrospun blend PET/PU scaffold: from fabrication to structural, mechanical, and in vitro evaluation
The development of small-diameter vascular grafts (SDVGs) remains a significant challenge and unsolved problem due to issues with compliance mismatch, thrombosis, and graft failure. This study explores electrospun blended scaffolds made from polyethylene terephthalate (PET) and polyurethane (PU), both Food and Drug Administration (FDA)-approved polymers, as potential candidates for small-diameter vascular applications. Nanofibrous scaffolds composed of blended PET and PU were fabricated using the electrospinning method. The morphological and chemical properties of the scaffolds were characterized by FE-SEM, porosity measurement, FTIR, and DSC. Comprehensive mechanical evaluations, including tensile strength, burst pressure, and compliance, were performed. Biocompatibility was assessed by examining cellular adhesion, proliferation, and viability on the scaffolds. For in vivo evaluation, the electrospun scaffolds were subcutaneously implanted in rats. The PET/PU blended scaffolds exhibited excellent physicochemical compatibility, with mechanical properties within the range of native small-diameter blood vessels (SDBVs). Burst pressure and compliance evaluations demonstrated the ability of the PET/PU blend to mitigate the compliance mismatch commonly observed in synthetic grafts. Additionally, the scaffolds supported strong human cell adhesion, proliferation, and high cell viability, indicating good biocompatibility. No signs of necrosis, calcification, severe fibrosis, inflammation, or foreign body granulomatous reaction were observed following subcutaneous implantation of the scaffolds. Electrospun PET/PU scaffolds offer promising mechanical and biocompatible properties for SDVGs applications. The ability to address compliance mismatch, combined with excellent cellular support, positions these scaffolds as a strong candidate for clinical use. However, further preclinical and clinical studies are necessary to validate their long-term safety, performance, and commercial viability.
- Open Access
- 25 March 2025
- Published by Elsevier in Journal of Tissue Viability
- Vol. 34 (3) , 100888
Assessment of the structural and histopathological challenges of binary electrospun PET-based nanofibers for tissue engineering applications
- 25 March 2025
- Published by Elsevier in Journal of Tissue Viability
- Vol. 34 (3) , 100888
Open AccessAssessment of the structural and histopathological challenges of binary electrospun PET-based nanofibers for tissue engineering applications
- Open Access
- 1 October 2023
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 31 (148) , 449-456
Function Assessment of a Fabricated Artificial Vascular Graft in Sheep Carotid Artery
Background and Objective: In the field of vascular surgery, the use of tissue-engineered vascular grafts is advancing and new synthetic tissues are being utilized to replace damaged blood vessels. These synthetic vessels, made through tissue engineering techniques, must mimic the shape and mechanical properties of native vessels. This study was performed ...
- 1 October 2023
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 31 (148) , 449-456
Open AccessFunction Assessment of a Fabricated Artificial Vascular Graft in Sheep Carotid Artery
Background and Objective: In the field of vascular surgery, the use of tissue-engineered vascular grafts is advancing and new synthetic tissues are being utilized to replace damaged blood vessels. These synthetic vessels, made through tissue engineering techniques, must mimic the shape and mechanical properties of native vessels. This study was performed ...
- Open Access
- 1 June 2022
- Published by SAGE Publications in Journal of Industrial Textiles
- Vol. 52
A review on developments of in-vitro and in-vivo evaluation of hybrid PCL-based natural polymers nanofibers scaffolds for vascular tissue engineering
The main objective of the present review article is to investigate the in-vitro and in-vivo biocompatibility behavior of hybrid PCL-based scaffolds with collagen, gelatin, and chitosan to improve endothelialization for VTE applications. It is reported that the high-rate failure of small diameters vascular grafts (SDVGs, <6 mm) due to adhesion of platelets and plasma protein and aggregation, over-proliferation of smooth muscle cells (SMCs), and neointimal hyperplasia at the implantation site is main challenge in vascular tissue engineering (VTE). The fast re-establishment of a functional endothelial cell (EC) layer representing a crucial importance strategy has been proposed to reduce these adverse outcomes. Polycaprolactone (PCL), with optimum mechanical properties, it showed great potential in biomedical applications, but its biocompatibility is still highly concerned in VTE. Modifications of the PCL vascular grafts by developing the hybrid structures using natural polymers with optimum hydrophilicity and biocompatibility properties in order to speed up the re-endothelialization process have been proposed over the last years. Analyzing the mentioned results in the present study can offer a better understanding of the benefits and challenges of applying the natural polymer as a thrombotic response upon implantation in clinical trials. Also, it can suggest the PCL-Collagen as the best framework for the fabrication of rationally designed SDVGs for VTE.
- 1 June 2022
- Published by SAGE Publications in Journal of Industrial Textiles
- Vol. 52
Open AccessA review on developments of in-vitro and in-vivo evaluation of hybrid PCL-based natural polymers nanofibers scaffolds for vascular tissue engineering
The main objective of the present review article is to investigate the in-vitro and in-vivo biocompatibility behavior of hybrid PCL-based scaffolds with collagen, gelatin, and chitosan to improve endothelialization for VTE applications. It is reported that the high-rate failure of small diameters vascular grafts (SDVGs, <6 mm) due to adhesion of platelets and plasma protein and aggregation, over-proliferation of smooth muscle cells (SMCs), and neointimal hyperplasia at the implantation site is main challenge in vascular tissue engineering (VTE). The fast re-establishment of a functional endothelial cell (EC) layer representing a crucial importance strategy has been proposed to reduce these adverse outcomes. Polycaprolactone (PCL), with optimum mechanical properties, it showed great potential in biomedical applications, but its biocompatibility is still highly concerned in VTE. Modifications of the PCL vascular grafts by developing the hybrid structures using natural polymers with optimum hydrophilicity and biocompatibility properties in order to speed up the re-endothelialization process have been proposed over the last years. Analyzing the mentioned results in the present study can offer a better understanding of the benefits and challenges of applying the natural polymer as a thrombotic response upon implantation in clinical trials. Also, it can suggest the PCL-Collagen as the best framework for the fabrication of rationally designed SDVGs for VTE.
- 3 March 2022
- Published by SAGE Publications in Journal of Industrial Textiles
- Vol. 51 (4_suppl) , 6816S-6837S
Pathological examination of blended and co-electrospinning hybrid polycaprolactone/polyurethane nanofibers for soft tissue engineering applications
The main objective of soft tissue engineering (STE) is to improve the quality of life by replacing damaged tissues with synthetic scaffolds. Collagen is the key structural protein of the native extracellular matrix with nano-scale diameter. Accordingly, this study focused on the fabrication of the blended and co-electrospinning hybrid synthetic polycaprolactone/polyurethane (PCL/PU) nanofibers scaffolds and investigates their in-vivo biocompatibility for the development of their clinical applications in STE. The body reactions were evaluated by examination of the edema, foreign body granulomatous reaction, granulation tissue formation, inflammation, calcification, fibroblastic change, and necrosis as the most important healing effects in pathology examination. The blended and co-electrospinning PCL/PU structures were successfully carried out in the nano-scale range without any beads. According to the histopathological examination of PCL, the scant, mild and mild to moderate, and acute and chronic have been reported for edema, foreign body granulomatous reaction, and inflammation, respectively. Also, severe (for edema), moderate (for foreign body granulomatous reaction), and mild to moderate chronic (for inflammation) were observed for PU. In blended PCL/PU nanofibers, decreasing of the edema and foreign body granulomatous reaction and increasing of the granulation tissue formation and inflammation were observed with the increasing composite ratio of PCL from 25 to 75%. Also in the co-electrospinning hybrid PCL/PU nanofibers, increasing edema, granulation tissue formation, and inflammation were observed by increasing the composite ratio of PU from 25 to 75%. Present study suggested that blended hybrid PCL75/PU25 nanofibers are a promising candidate as synthetic nanofibers scaffolds for STE applications.
- 3 March 2022
- Published by SAGE Publications in Journal of Industrial Textiles
- Vol. 51 (4_suppl) , 6816S-6837S
Pathological examination of blended and co-electrospinning hybrid polycaprolactone/polyurethane nanofibers for soft tissue engineering applications
The main objective of soft tissue engineering (STE) is to improve the quality of life by replacing damaged tissues with synthetic scaffolds. Collagen is the key structural protein of the native extracellular matrix with nano-scale diameter. Accordingly, this study focused on the fabrication of the blended and co-electrospinning hybrid synthetic polycaprolactone/polyurethane (PCL/PU) nanofibers scaffolds and investigates their in-vivo biocompatibility for the development of their clinical applications in STE. The body reactions were evaluated by examination of the edema, foreign body granulomatous reaction, granulation tissue formation, inflammation, calcification, fibroblastic change, and necrosis as the most important healing effects in pathology examination. The blended and co-electrospinning PCL/PU structures were successfully carried out in the nano-scale range without any beads. According to the histopathological examination of PCL, the scant, mild and mild to moderate, and acute and chronic have been reported for edema, foreign body granulomatous reaction, and inflammation, respectively. Also, severe (for edema), moderate (for foreign body granulomatous reaction), and mild to moderate chronic (for inflammation) were observed for PU. In blended PCL/PU nanofibers, decreasing of the edema and foreign body granulomatous reaction and increasing of the granulation tissue formation and inflammation were observed with the increasing composite ratio of PCL from 25 to 75%. Also in the co-electrospinning hybrid PCL/PU nanofibers, increasing edema, granulation tissue formation, and inflammation were observed by increasing the composite ratio of PU from 25 to 75%. Present study suggested that blended hybrid PCL75/PU25 nanofibers are a promising candidate as synthetic nanofibers scaffolds for STE applications.